VIM
UTHR icon

Vinva Investment Management’s United Therapeutics UTHR Stock Holding History

Vinva Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.2M Buy
88,369
+19,761
+29% +$11.1M 0.32% 79
2026
Q1 		$40.4M Buy
68,608
+19,649
+40% +$9.79M 0.5% 43
2025
Q4 		$24.3M Buy
48,959
+23,995
+96% +$11.2M 0.3% 81
2025
Q3 		$10.6M Sell
24,964
-14,502
-37% -$4.88M 0.21% 127
2025
Q2 		$11.2M Buy
39,466
+30,734
+352% +$9.19M 0.29% 88
2025
Q1 		$2.68M Sell
8,732
-10,792
-55% -$3.7M 0.11% 195
2024
Q4 		$6.98M Sell
19,524
-10,085
-34% -$3.71M 0.27% 85
2024
Q3 		$10.6M Sell
29,609
-5,294
-15% -$1.79M 0.45% 50
2024
Q2 		$11.2M Buy
34,903
+14,829
+74% +$3.92M 0.56% 32
2024
Q1 		$4.61M Buy
20,074
+11,727
+140% +$2.65M 0.26% 100
2023
Q4 		$1.83M Buy
8,347
+2,914
+54% +$672K 0.12% 188
2023
Q3 		$1.23M Buy
5,433
+4,258
+362% +$981K 0.11% 185
2023
Q2 		$258K Sell
1,175
-130
-10% -$28.8K 0.02% 355
2023
Q1 		$286K Buy
+1,305
New +$322K 0.02% 371

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Vinva Investment Management's UTHR Position: Q2 2026 in Review

Vinva Investment Management increased its United Therapeutics (UTHR) stake by 29% in Q2 2026, buying an estimated $11.1M and bringing the position to 88,369 shares worth $48.2M. The position accounts for 0.32% of the portfolio, ranked #79.

Vinva Investment Management first reported a position in UTHR in Q1 2023 and has held it in 14 quarters since. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Vinva Investment Management held 88,369 shares of United Therapeutics worth $48.2M as of Q2 2026.
  • Vinva Investment Management bought 19,761 United Therapeutics shares in Q2 2026, an estimated $11.1M.
  • United Therapeutics made up 0.32% of Vinva Investment Management's portfolio in Q2 2026, its #79 holding.
  • Vinva Investment Management first reported a position in United Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.